RNA 3'end tailing safeguards cells against products of pervasive transcription termination.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. The RNA exosome: mechanisms of RNA surveillance, regulation, and disease.RNA biology · 2026
   Review
2. Enhancer RNAs: similarities with both lncRNAs and mRNAs reveal novel functions.RNA biology · 2026
   Review
3. Analysis of host and viral nascent and steady-state RNA levels in a human neuronal model of herpes simplex virus 1 infection.PLoS pathogens · 2026
   Article
4. Mechanisms of transcription termination across the coding and noncoding loci of the genome.Nature reviews. Molecular cell biology · 2026
   Review
5. Molecular basis of polyadenylated RNA fate determination in the nucleus.Nature · 2026
   Article
6. RNA 3'end tailing safeguards cells against products of pervasive transcription termination.Nature communications · 2024
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

Abstract

Indexed as